|
Overall
n=144
|
TOL group
n=84
|
PCS group
n=60
|
p value
|
OR (95% CI)
|
aOR (95% CI)**
|
Composite perinatal morbidity, n(%) |
8 (5.6) |
3 (3.6) |
5
(8.3) |
0.22 |
2.46 (0.56-10.69) |
1.36 (0.24-7.81) |
First twin |
4 (5.6) |
2 (4.8) |
2 (3.3) |
0.73 |
1.43 (0.19-10.75) |
0.77 (0.074-8.04) |
Second twin |
4 (5.6) |
1 (2.4) |
3 (5) |
0.16 |
4.56 (0.45-46.11) |
3.20 (0.16-65.88) |
> 34 week’s |
4/124 (3.2) |
2/80 (2.5) |
2/44 (4.5) |
0.54 |
1.86 (0.25-13.66) |
4.69 (0.85-25.81) |
> 36 week’s |
3/86 (3.5) |
1/56 (1.8) |
2/30 (6.7) |
0.24 |
3.93 (0.34-45.22) |
5.21 (0.49-55.63) |
5-minute Apgar score <4 |
0 |
0 |
0 |
- |
* |
* |
5-minute Apgar score <7 |
1 (0.7) |
1 (1.2) |
0 |
>0.99 |
* |
* |
Neonatal death |
0 |
0 |
0 |
- |
* |
* |
Respiratory morbidity (respiratory distress síndrome and/or
bronchopulmonary dysplasia) |
0 |
0 |
0 |
- |
* |
* |
Intraventricular hemorrhage |
5 (3.5) |
2 (2.4) |
3 (5.0) |
0.40 |
2.16 (0.35-13.33) |
1.64 (0.19-14.57) |
Periventricular leukomalacia |
1 (0.7) |
0 |
1 (1.7) |
0.42 |
* |
* |
Necrotizing enterocolitis |
1 (0.7) |
0 |
1 (1.7) |
0.42 |
* |
* |
Sepsis |
0 |
0 |
0 |
- |
* |
* |
2-year-Neurodevelopmental impairment, n(%) |
10/140 (7.1) |
4/81 (4.9) |
6 / 59 (10.2) |
0.26 |
2.11 (0.57-7.84) |
1.53
(0.37-6.29) |
Severe neurodevelopmental impairment |
2/140 (1.4) |
0 |
2 / 59 (3.4) |
0.18 |
* |
* |